DK162284C - Analogifremgangsmaade til fremstilling af 2-oe4-oe(4-substituerede-2,6-piperidindion-1-yl)butylaa-1-piperazinylaa-3-cyanopyridiner - Google Patents

Analogifremgangsmaade til fremstilling af 2-oe4-oe(4-substituerede-2,6-piperidindion-1-yl)butylaa-1-piperazinylaa-3-cyanopyridiner

Info

Publication number
DK162284C
DK162284C DK573282A DK573282A DK162284C DK 162284 C DK162284 C DK 162284C DK 573282 A DK573282 A DK 573282A DK 573282 A DK573282 A DK 573282A DK 162284 C DK162284 C DK 162284C
Authority
DK
Denmark
Prior art keywords
piperidindion
piperazinylaa
butylaa
cyanopyridines
substituted
Prior art date
Application number
DK573282A
Other languages
Danish (da)
English (en)
Other versions
DK573282A (da
DK162284B (da
Inventor
Davis L Temple
Joseph P Yevich
Walter G Lobeck
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK573282A publication Critical patent/DK573282A/da
Publication of DK162284B publication Critical patent/DK162284B/da
Application granted granted Critical
Publication of DK162284C publication Critical patent/DK162284C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
DK573282A 1981-12-28 1982-12-23 Analogifremgangsmaade til fremstilling af 2-oe4-oe(4-substituerede-2,6-piperidindion-1-yl)butylaa-1-piperazinylaa-3-cyanopyridiner DK162284C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33468981 1981-12-28
US06/334,689 US4361565A (en) 1981-12-28 1981-12-28 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Publications (3)

Publication Number Publication Date
DK573282A DK573282A (da) 1983-06-29
DK162284B DK162284B (da) 1991-10-07
DK162284C true DK162284C (da) 1992-03-16

Family

ID=23308356

Family Applications (1)

Application Number Title Priority Date Filing Date
DK573282A DK162284C (da) 1981-12-28 1982-12-23 Analogifremgangsmaade til fremstilling af 2-oe4-oe(4-substituerede-2,6-piperidindion-1-yl)butylaa-1-piperazinylaa-3-cyanopyridiner

Country Status (27)

Country Link
US (1) US4361565A (sv)
JP (1) JPS58118583A (sv)
KR (1) KR880002011B1 (sv)
AT (1) AT380880B (sv)
AU (1) AU560667B2 (sv)
BE (1) BE895505A (sv)
CA (1) CA1237722A (sv)
CH (1) CH653682A5 (sv)
CY (1) CY1378A (sv)
DE (1) DE3248138A1 (sv)
DK (1) DK162284C (sv)
ES (1) ES8402832A1 (sv)
FI (1) FI70892C (sv)
FR (1) FR2518994B1 (sv)
GB (1) GB2114121B (sv)
GR (1) GR77101B (sv)
HK (1) HK5188A (sv)
HU (1) HU190827B (sv)
IE (1) IE54620B1 (sv)
IT (1) IT1158040B (sv)
KE (1) KE3714A (sv)
LU (1) LU84562A1 (sv)
NL (1) NL8204974A (sv)
PT (1) PT76037B (sv)
SE (1) SE449748B (sv)
SG (1) SG29687G (sv)
ZA (1) ZA828546B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387221B (de) * 1980-09-08 1988-12-27 Bristol Myers Co Verfahren zur herstellung des neuen
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
CA1278792C (en) * 1985-05-06 1991-01-08 Joseph P. Yevich Antipsychotic fused-ring pyridinylpiperazine derivatives
US4757073A (en) * 1986-09-30 1988-07-12 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use
US4855430A (en) * 1987-11-12 1989-08-08 American Home Products Corporation Polycyclicamine with psychotropic activity
EP0348460A4 (en) * 1987-11-12 1991-11-27 American Home Products Corporation Polycyclicamines with psychotropic activity
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
ATE132866T1 (de) * 1990-10-23 1996-01-15 Akzo Nobel Nv 4-(4- oder 6-(trifluormethyl-2-pyridinyl)>-1- piperazinyl-alkyl substituierte laktame
JPH06504279A (ja) * 1990-12-24 1994-05-19 メレルダウファーマス−ティカルズ インコーポレイテッド 欝病及び躁病の治療におけるある種のグルタルイミド誘導体の用途
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EA017351B1 (ru) * 2007-03-29 2012-11-30 Общество С Ограниченной Ответственностью "Фармвинг" Средство противогистаминного антиаллергического действия и способ его получения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
DK251079A (da) * 1978-06-20 1979-12-21 Synthelabo Fremgangsmaade til fremstilling af phenylpiperazinderivater
US4305944A (en) * 1980-09-08 1981-12-15 Mead Johnson & Company N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones

Also Published As

Publication number Publication date
PT76037B (en) 1985-12-16
GB2114121A (en) 1983-08-17
IE823068L (en) 1983-06-28
DE3248138A1 (de) 1983-07-07
AT380880B (de) 1986-07-25
ZA828546B (en) 1983-09-28
FI70892B (fi) 1986-07-18
KR840002826A (ko) 1984-07-21
SE449748B (sv) 1987-05-18
KR880002011B1 (ko) 1988-10-12
FI70892C (fi) 1986-10-27
HU190827B (en) 1986-11-28
CY1378A (en) 1987-08-07
GR77101B (sv) 1984-09-06
IE54620B1 (en) 1989-12-20
SE8207426D0 (sv) 1982-12-27
DK573282A (da) 1983-06-29
ATA467682A (de) 1985-12-15
FI824443L (fi) 1983-06-29
JPH0567637B2 (sv) 1993-09-27
ES518511A0 (es) 1984-03-01
JPS58118583A (ja) 1983-07-14
FR2518994A1 (fr) 1983-07-01
AU9108482A (en) 1983-07-07
ES8402832A1 (es) 1984-03-01
HK5188A (en) 1988-01-29
AU560667B2 (en) 1987-04-16
PT76037A (en) 1983-01-01
FI824443A0 (fi) 1982-12-23
SE8207426L (sv) 1983-06-29
GB2114121B (en) 1985-11-27
LU84562A1 (fr) 1983-09-08
NL8204974A (nl) 1983-07-18
IT8249720A0 (it) 1982-12-22
IT1158040B (it) 1987-02-18
US4361565A (en) 1982-11-30
KE3714A (en) 1987-04-16
CH653682A5 (de) 1986-01-15
BE895505A (fr) 1983-06-28
FR2518994B1 (fr) 1986-09-05
DK162284B (da) 1991-10-07
SG29687G (en) 1987-07-17
CA1237722A (en) 1988-06-07
DE3248138C2 (sv) 1992-12-10

Similar Documents

Publication Publication Date Title
DK159442C (da) Analogifremgangsmaade til fremstilling af 6,7-substitueret-4-ethyl-quinazoliner
DK162389C (da) Analogifremgangsmaade til fremstilling af 2-oe4-oe(4,4-dialkyl-2,6-piperidindion-1-yl)butylaa-1-piperazinylaapyrimidiner
DK89783A (da) Fremgangsmaade til fremstilling af 3-keto-delta4,9-19-nor-steroidderivater
DK161325C (da) Analogifremgangsmaade til fremstilling af imidazooe4,5-caa-pyridinderivater
DK68285A (da) N-aryl-3-aryl-4,5-dihydro-1h-pyrazol-1-carboxamider, fremgangsmaade til fremstilling af forbindelserne, insekticider indeholdende forbindelserne og fremgangsmaade til bekaempelse af insekter
DK153552C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinderivater
DK164593C (da) Analogifremgangsmaade til fremstilling af 1-phenyl-2-piperidinopropanolderivater
DK162284C (da) Analogifremgangsmaade til fremstilling af 2-oe4-oe(4-substituerede-2,6-piperidindion-1-yl)butylaa-1-piperazinylaa-3-cyanopyridiner
DK143491D0 (da) Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion
DK161147C (da) Analogifremgangsmaade til fremstilling af oe3haa-imidazo-oe5,1-daa-1,2,3,5-tetrazin-4-onderivater
DK153844C (da) Analogifremgangsmaade til fremstilling af 1,2,3,5-tetrahydroimidazothienopyrimidin-2-oner
DK150070C (da) Analogifremgangsmaade til fremstilling af n-dihydrothiazolyl-3-quinolincarboxamidderivater
DK157855C (da) Fremgangsmaade til fremstilling af 2,3-dichlor-5-trichlormethylpyridin
DK156722C (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
DK400381A (da) Fremgansmaade til fremstilling af penicillanoyloxymethyl-penicillanoyloxymethyl-penicillanat-1,1,1!,1!-tetraoxid
DK159681A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-methanaminer
DK160489C (da) Fremgangsmaade til fremstilling af 2,3-difluorpyridinforbindelser
DK162718C (da) Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser
DK156635C (da) Analogifremgangsmaade til fremstilling af 24,24-difluor-25-hydroxycholecalciferol
DK163000C (da) Analogifremgangsmaade til fremstilling af vinylthioacetamido-1-dethia-1-oxa-cephalosporinderivater
DK146067C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-phenoxypropoxypyrimidiner
DK153488C (da) Fremgangsmaade til fremstilling af 5,6,7,7a-tetrahydro-4h-thieno(3,2-c-)-pyridin-2-onderivater
DK153838C (da) Analogifremgangsmaade til fremstilling af 2,4-dichlor-alfa-(n-imidazolylmethyl)-dibenzylethere
DK159108C (da) Analogifremgangsmaade til fremstilling af 6-anilino-5,8-quinoxalindioner
DK513580A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa (polyhalogenalkyl)-1h-imidazol-2-methanoler